Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed Oct 10, 2014 · 10-Q · 10 days after period end · 0001193125-14-369132
| Metric | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$740.07K | -$1.29M | $640.29K |
| EPS Diluted | -$0.01 | -$0.07 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Oct 10, 2014 · 10 d after period end
